Mediclin AG operates in the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mediclin AG with three other
health care providers in Europe:
Md Medical Group Investments Plc
sales of 202.25 million Euro [US$228.53 million]
Aevis Victoria SA
(577.03 million Swiss Francs [US$570.75 million]
of which 86%
was Hospitals), and
Spire Healthcare Group PLC
based in the United Kingdom
(£931.10 million [US$1.21 billion]
of which 100%
was Healthcare Services).
Mediclin AG reported sales of 654.95 million Euro (US$740.06 million)
December of 2018.
increase of 4.6%
versus 2017, when the company's sales were 626.41 million Euro.
Sales at Mediclin AG have increased during each of the previous five years
(and since 2013, sales have increased a total of 25%).
Sales of Post Acute saw an increase
7.4% in 2018, from
378.70 million Euro to 406.90 million Euro.
Not all segments of Mediclin AG experienced an increase in sales in 2018:
sales of Other Activities fell 1.0% to 76.30 million Euro.